医薬品分析試験アウトソーシング市場：サービス、試験手法、最終用途別-2025-2030年の世界予測

医薬品分析試験アウトソーシング市場は、2023年に92億3,000万米ドルと評価され、2024年には100億7,000万米ドルに達すると予測され、CAGR 9.38%で成長し、2030年には173億米ドルになると予測されています。

医薬品分析試験アウトソーシングは、医薬品のラボ試験や分析評価を外部機関に委託することを指します。専門知識、コスト効率、規制遵守、コアコンピテンシーへの集中などのニーズがあります。用途としては、安定性試験、方法バリデーション、原料分析、微生物試験などがあり、最終用途としては、製薬、バイオテクノロジー企業、医療機器などがあります。主な成長促進要因としては、医薬品開発の複雑化、規制の厳格化、医薬品開発におけるコスト削減の推進などが挙げられます。分析検査へのAIや機械学習のような先進技術の採用が増加していることは、潜在的な機会を提示しています。企業は、精度と効率を向上させるためにこれらの技術を活用し、サービス能力と地理的範囲を拡大するために戦略的パートナーシップを模索することが推奨されます。しかし、データセキュリティの潜在的な課題、タイムラインに影響を及ぼす可能性のある外部機関への依存リスク、世界企業間の品質基準のばらつきといった要因によって、成長は妨げられます。また、進化する国際的な規制基準に厳格に準拠する必要性も、制約要因となっています。市場開拓は、パーソナライズされた検査ソリューションの開発、予測的品質評価のためのビッグデータ解析の統合、スピードと精度を確保するための自動化システムの活用によって推進することができます。さらに、学術機関や技術系新興企業とのコラボレーションによって、新たな検査手法やスケーラブルなソリューションが生まれるかもしれないです。市場の性質はダイナミックで競争が激しく、既成のサービスプロバイダーと新興のプレーヤーが混在し、それぞれに合ったソリューションを提供しています。競合情勢が進化する中、企業は変化する業界ニーズに機敏に対応し、堅牢な品質管理の枠組みを確保しつつ、技術的進歩とトレーニングに継続的に投資して競争優位性を維持しなければならないです。企業は、コンプライアンス上の変化を先取りするために、規制当局と積極的に連携し、新しい慣行を業務ワークフローにシームレスに統合する必要があります。

市場力学：急速に進化する医薬品分析試験アウトソーシング市場の主要市場インサイトを公開

医薬品分析試験アウトソーシング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 創薬開発の研究開発の増加
  • 医薬品製剤の複雑化と厳しい規制基準への適合の必要性
  • コスト最適化戦略としての医薬品分析試験アウトソーシングへの嗜好の高まり
• 市場抑制要因
  • 分析機器と最新設備の維持にかかるコストの高さ
• 市場機会
  • 薬物検査手順における新たな技術進歩
  • 製薬業界への投資の増加
• 市場の課題
  • 知的財産権に関する懸念

ポーターのファイブフォース医薬品分析試験アウトソーシング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：医薬品分析試験アウトソーシング市場における外部からの影響の把握

外部マクロ環境要因は、医薬品分析試験アウトソーシング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析医薬品分析試験アウトソーシング市場における競合情勢の把握

医薬品分析試験アウトソーシング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス医薬品分析試験アウトソーシング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、医薬品分析試験アウトソーシング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨医薬品分析試験アウトソーシング市場における成功への道筋を描く

医薬品分析試験アウトソーシング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品の発見と開発における研究開発の増加
    • 薬剤処方の複雑さと厳格な規制基準への準拠の必要性
    • コスト最適化戦略としての医薬品分析試験アウトソーシングの好感度が高まっています
  • 抑制要因
    • 分析機器の高コストと最新設備の維持
  • 機会
    • 薬物検査手順における新たな技術的進歩
    • 製薬業界への投資増加
  • 課題
    • 知的財産権に関する懸念
• 市場セグメンテーション分析
  • サービス：医薬品の有効性と安全性を判断するためのバイオ分析試験サービスの需要
  • 試験技術：サンプル中の分析対象物を分離し定量化する効率性によるクロマトグラフィーの大きな利点
  • 最終用途：契約製造組織による幅広い高度に複雑なテストサービスに対する需要の高まり
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 医薬品分析試験アウトソーシング市場：サービス別

• 生体分析試験
  • 臨床
  • 非臨床
• 方法の開発と検証
  • 抽出可能および浸出可能
  • 不純物法
  • 技術コンサルティング
• 安定性テスト
  • 加速安定性試験
  • 薬物成分
  • 光安定性試験
  • 安定性指示法の検証

第7章 医薬品分析試験アウトソーシング市場テスト手法別

• クロマトグラフィー
• 質量分析
• 分光法

第8章 医薬品分析試験アウトソーシング市場：最終用途別

• バイオ医薬品および医薬品
• 契約製造組織

第9章 南北アメリカの医薬品分析試験アウトソーシング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の医薬品分析試験アウトソーシング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの医薬品分析試験アウトソーシング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • スターリング・アキュリス、新たな買収により医薬品および分析試験分野に進出
  • ユーロフィンは、日本におけるアステラス製薬とのアウトソーシング契約により、バイオ医薬品製品の試験拠点を拡大
• 戦略分析と提言

企業一覧

• Ajinomoto Bio-Pharma
• Alcami Corporation
• AptarGroup, Inc.
• Ascendia Pharmaceuticals
• BioAgilytix
• Cambrex Corporation
• Catalent, Inc
• Charles River Laboratories International, Inc.
• Element Materials Technology
• Eurofins Scientific SE
• ICON PLC
• Intertek Group PLC
• Laboratory Corporation of America Holdings
• LGM Pharma
• Medpace Holdings, Inc.
• Merck KGaA
• Pace Analytical Services, Inc.
• SGS SA
• Societal CDMO
• Source BioScience
• Syneos Health
• Thermo Fisher Scientific Inc.
• West Pharmaceutical Services, Inc.
• WuXi AppTec

LIST OF FIGURES

• FIGURE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET RESEARCH PROCESS
• FIGURE 2. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET DYNAMICS
• TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY NON-CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY EXTRACTABLE & LEACHABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY IMPURITY METHOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TECHNICAL CONSULTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY ACCELERATED STABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY DRUG SUBSTANCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY PHOTOSTABILITY TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY INDICATING METHOD VALIDATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOPHARMACEUTICALS & PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 50. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 51. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 52. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 53. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 54. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 82. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 83. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 84. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 85. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 86. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 87. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 88. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 89. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 90. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 91. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 92. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 191. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 192. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 193. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 194. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 195. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 214. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 215. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 216. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 217. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 218. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 219. POLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 220. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 221. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 222. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 223. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 224. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 225. QATAR PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT & VALIDATION, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY STABILITY TESTING, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY TESTING TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SIZE, BY BIOANALYTICAL TESTING, 2018-2030 (USD MILLION)

TABLE

The Pharmaceutical Analytical Testing Outsourcing Market was valued at USD 9.23 billion in 2023, expected to reach USD 10.07 billion in 2024, and is projected to grow at a CAGR of 9.38%, to USD 17.30 billion by 2030.

Pharmaceutical Analytical Testing Outsourcing refers to contracting external organizations to conduct laboratory testing and analytical assessments of pharmaceutical products. It is necessitated by a need for specialized expertise, cost efficiency, regulatory compliance, and the ability to focus on core competencies. Applications include stability testing, method validation, raw material analysis, and microbiological testing, while end-use avenues cover pharmaceuticals, biotechnology firms, and medical devices. Key growth drivers include the rising complexity of drug development, stringent regulatory mandates, and the push for cost reduction in pharmaceutical development. The increasing adoption of advanced technologies like AI and machine learning for analytical testing presents potential opportunities; companies are recommended to leverage these technologies to improve accuracy and efficiency and explore strategic partnerships to expand service capabilities and geographical reach. However, growth is challenged by factors such as potential breaches in data security, dependency risks on external agencies that could affect timelines, and variability in quality standards across global players. The need for rigorous compliance with evolving international regulatory standards also poses a limitation. Market innovation can be driven by developing personalised testing solutions, integrating big data analytics for predictive quality assessments, and leveraging automated systems to ensure speed and precision. Moreover, collaboration with academic institutions and tech startups might yield new testing methodologies and scalable solutions. The nature of the market is dynamic and competitive, with a mix of established service providers and emerging players offering tailored solutions. As the landscape evolves, businesses must remain agile and responsive to changing industry needs, ensuring robust quality control frameworks while continuously investing in technological advancements and training to maintain a competitive advantage. Companies should proactively engage with regulatory bodies to stay ahead of compliance changes, ensuring seamless integration of new practices into their operational workflows.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pharmaceutical Analytical Testing Outsourcing Market

The Pharmaceutical Analytical Testing Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing research and development in drug discovery and development
  • Complexity of drug formulations and need for compliance with stringent regulatory standards
  • Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
• Market Restraints
  • High cost of analytical instruments and maintaining state-of-the-art facilities
• Market Opportunities
  • Emerging technological advancements in drug testing procedures
  • Increasing investments in the pharmaceutical industry
• Market Challenges
  • Concerns associated with intellectual property rights

Porter's Five Forces: A Strategic Tool for Navigating the Pharmaceutical Analytical Testing Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pharmaceutical Analytical Testing Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pharmaceutical Analytical Testing Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pharmaceutical Analytical Testing Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pharmaceutical Analytical Testing Outsourcing Market

A detailed market share analysis in the Pharmaceutical Analytical Testing Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pharmaceutical Analytical Testing Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pharmaceutical Analytical Testing Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pharmaceutical Analytical Testing Outsourcing Market

A strategic analysis of the Pharmaceutical Analytical Testing Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pharmaceutical Analytical Testing Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Bio-Pharma, Alcami Corporation, AptarGroup, Inc., Ascendia Pharmaceuticals, BioAgilytix, Cambrex Corporation, Catalent, Inc, Charles River Laboratories International, Inc., Element Materials Technology, Eurofins Scientific SE, ICON PLC, Intertek Group PLC, Laboratory Corporation of America Holdings, LGM Pharma, Medpace Holdings, Inc., Merck KGaA, Pace Analytical Services, Inc., SGS SA, Societal CDMO, Source BioScience, Syneos Health, Thermo Fisher Scientific Inc., West Pharmaceutical Services, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Pharmaceutical Analytical Testing Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Services, market is studied across Bioanalytical Testing, Method Development & Validation, and Stability Testing. The Bioanalytical Testing is further studied across Clinical and Non-Clinical. The Method Development & Validation is further studied across Extractable & Leachable, Impurity Method, and Technical Consulting. The Stability Testing is further studied across Accelerated Stability Testing, Drug Substance, Photostability Testing, and Stability Indicating Method Validation.
• Based on Testing Technique, market is studied across Chromatography, Mass Spectrometry, and Spectroscopy.
• Based on End-use, market is studied across Biopharmaceuticals & Pharmaceuticals and Contract Manufacturing Organizations.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing research and development in drug discovery and development
    • 5.1.1.2. Complexity of drug formulations and need for compliance with stringent regulatory standards
    • 5.1.1.3. Growing preferences for pharmaceutical analytical testing outsourcing as a cost optimization strategy
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of analytical instruments and maintaining state-of-the-art facilities
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging technological advancements in drug testing procedures
    • 5.1.3.2. Increasing investments in the pharmaceutical industry
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with intellectual property rights
• 5.2. Market Segmentation Analysis
  • 5.2.1. Services: Demand for bioanalytical testing services to determine efficacy and safety of pharmaceutical products
  • 5.2.2. Testing Technique: Significant benefits of chromatography owing to its efficiency in separating and quantifying analytes in samples
  • 5.2.3. End-use: Growing need for a broad range of high-complexity testing services from contract manufacturing organizations
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pharmaceutical Analytical Testing Outsourcing Market, by Services

• 6.1. Introduction
• 6.2. Bioanalytical Testing
  • 6.2.1. Clinical
  • 6.2.2. Non-Clinical
• 6.3. Method Development & Validation
  • 6.3.1. Extractable & Leachable
  • 6.3.2. Impurity Method
  • 6.3.3. Technical Consulting
• 6.4. Stability Testing
  • 6.4.1. Accelerated Stability Testing
  • 6.4.2. Drug Substance
  • 6.4.3. Photostability Testing
  • 6.4.4. Stability Indicating Method Validation

7. Pharmaceutical Analytical Testing Outsourcing Market, by Testing Technique

• 7.1. Introduction
• 7.2. Chromatography
• 7.3. Mass Spectrometry
• 7.4. Spectroscopy

8. Pharmaceutical Analytical Testing Outsourcing Market, by End-use

• 8.1. Introduction
• 8.2. Biopharmaceuticals & Pharmaceuticals
• 8.3. Contract Manufacturing Organizations

9. Americas Pharmaceutical Analytical Testing Outsourcing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pharmaceutical Analytical Testing Outsourcing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pharmaceutical Analytical Testing Outsourcing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Sterling Accuris expands into pharmaceutical and analytical testing through new acquisition
  • 12.3.2. Eurofins expands its biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Ajinomoto Bio-Pharma
• 2. Alcami Corporation
• 3. AptarGroup, Inc.
• 4. Ascendia Pharmaceuticals
• 5. BioAgilytix
• 6. Cambrex Corporation
• 7. Catalent, Inc
• 8. Charles River Laboratories International, Inc.
• 9. Element Materials Technology
• 10. Eurofins Scientific SE
• 11. ICON PLC
• 12. Intertek Group PLC
• 13. Laboratory Corporation of America Holdings
• 14. LGM Pharma
• 15. Medpace Holdings, Inc.
• 16. Merck KGaA
• 17. Pace Analytical Services, Inc.
• 18. SGS SA
• 19. Societal CDMO
• 20. Source BioScience
• 21. Syneos Health
• 22. Thermo Fisher Scientific Inc.
• 23. West Pharmaceutical Services, Inc.
• 24. WuXi AppTec